TRANSKARYOTIC THERAPIES INC
S-3, EX-23.1, 2000-12-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TRANSKARYOTIC THERAPIES INC, S-3, EX-12.1, 2000-12-13
Next: OPHTHALMIC IMAGING SYSTEMS INC, 10KSB, 2000-12-13



<PAGE>


                                                                  EXHIBIT 23.1

                       CONSENT OF INDEPENDENT AUDITORS

         We consent to the reference to our firm under the caption "Experts"
in the Registration Statement (Form S-3) and related Prospectus of
Transkaryotic Therapies, Inc., for the registration of $500,000,000 of
securities and to the incorporation by reference therein of our report dated
February 4, 2000, with respect to the consolidated financial statements of
Transkaryotic Therapies, Inc. included in its Annual Report (Form 10-K) for
the year ended December 31, 1999, filed with the Securities and Exchange
Commission.

                                                     /s/ Ernst & Young LLP


Boston, Massachusetts
December 11, 2000






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission